Transfer of group A streptococcal pyrogenic exotoxin production to nontoxigenic strains of lysogenic conversion.

Infection and Immunity
L P JohnsonD W Watson

Abstract

Production of group A streptococcal pyrogenic exotoxins (SPE) type A and C was transferred from toxigenic streptococcal strains to nontoxigenic strains by lysogeny. Lysogens were tested for SPE with Ouchterlony immunodiffusion on Todd-Hewitt agar plates; toxin diffusing from isolated colonies reacted with specific hyperimmune antisera to SPE. Phage prepared from strains T25(3) (T12gl) and 3GL16, both yielding SPE type A, formed plaques on T25(3) (NONLYSOGENIC) lawns. Over 90% of the colonies picked from the plaque centers yielded A toxin, suggesting SPE type A was transferred by lysogenic conversion. SPE type C formation was transferred to nontoxigenic strains T25(3) and K56 with supernatant fluids from mitomycin C-induced cultures of CS112, producing SPE types B and C. All lysogens tested were positive for SPE type C, indicating that C toxin induction also was transferred by lysogenic conversion. SPE type B formation was not transferable by lysogeny with the strains tested.

Citations

Jan 1, 1990·Critical Reviews in Microbiology·G A BohachP M Schlievert
Aug 1, 1987·Molecular & General Genetics : MGG·G A Bohach, P M Schlievert
Jan 1, 1983·Molecular & General Genetics : MGG·L P Johnson, P M Schlievert
Feb 17, 2001·Infection and Immunity·J K McCormickP M Schlievert
May 16, 2002·Infection and Immunity·Tadayoshi IkebeUNKNOWN Working Group for Group A Streptococcus in Japan
Jan 1, 1984·Molecular & General Genetics : MGG·L P Johnson, P M Schlievert
May 1, 1986·Acta paediatrica Scandinavica·C P SpeerM J Pabst
Apr 1, 1988·Molecular & General Genetics : MGG·S C GoshornP M Schlievert
Sep 7, 2001·Annual Review of Microbiology·J K McCormickP M Schlievert
Aug 18, 1999·Proceedings of the National Academy of Sciences of the United States of America·E A Miao, S I Miller
Jan 9, 2008·The Journal of Infectious Diseases·Ivo VojtekEmmanuelle Charpentier
Aug 1, 1990·Oral Microbiology and Immunology·R H StevensD H Fine
Jun 22, 2001·Microbes and Infection·R P NovickA Ruzin
Jun 1, 1989·Journal of Bacteriology·S C Goshorn, P M Schlievert
May 1, 1982·Infection and Immunity·S K Nida, J J Ferretti
May 1, 1986·Journal of Bacteriology·L P JohnsonP M Schlievert

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.